期刊文献+

尘肺病患者疾病认知能力测评量表的研制与评价 被引量:5

Development and evaluation of a scale for pneumoconiosis patients' cognitive ability to this disease
原文传递
导出
摘要 [目的]编制适用于尘肺病患者疾病认知能力的测评工具,并检验其信度和效度。[方法]以疾病认知为理论框架,在查阅文献、专家咨询的基础上设计初始量表;采用目标抽样方法对深圳市职业病防治院及湖南省职业病防治院住院的尘肺病患者173例进行问卷调查,使用Cronbach’sα系数、因子分析等统计学方法,对量表的信度、效度进行检验。[结果]发放问卷173份,回收168份,回收率97.11%。经探索因子分析,最终形成4个一级维度[即尘肺病基础知识、运动肺(康复)训练相关知识、戒烟相关知识、尘肺病治疗相关知识],15个二级维度,75个三级条目的尘肺病患者疾病认知能力测评量表。该量表的总体Cronbach’sα系数为0.938,各维度Cronbach’sα系数为0.899~0.952,可解释总的变异(累计方差贡献率)为83.351%,项目负荷值为0.714~0.920。[结论]尘肺病患者疾病认知能力测评量表的建构基本符合理论构想,适用于评估患者或作为一种横断面调查工具。 [Objective] To develop a measuring scale for pneumoconiosis patients' cognitive ability to this disease and test its reliability and validity. [Methods] After consulting with specialists, a prime scale was designed based on the referring documents. Totally 173 pneumoconiosis patients were investigated by the scale with a target sampling at Shenzhen Prevention and Treatment Center for Occupational Diseases and Hunan Prevention and Treatment Center for Occupational Diseases. The reliability and validity of the scale was tested by Cronbach's α coefficient and factor analysis. [Results] A scale for patients' cognitive ability to pneumoconiosis was developed, consisting of 4 one-level dimensions(such as basic knowledge of pneumoconiosis,knowledge of sports rehabilitation,knowledge of smoking cessation,treatment knowledge of pneumoconiosis),15 two-level dimensions and 75 three-level items. Totally 168 questionnaires were gotten. Cronbach 's α coefficient of full scale was 0.938,and the Cronbach's α coefficients of two-level dimensions were from 0.899 to 0.952,which indicated 83.351% of the total variation(contribution rate of accumulative variation).The entries' loading values were from 0.714 to 0.200.[Conclusion] The scale for patients' cognitive ability to pneumoconiosis basically accorded with theoretical composition,and it is appropriate to evaluate pneumoconiosis patients or to be an investigation instrument in a cross-sectional study.
作者 刘璐 章一华 朱德香 梁实 李爱清 LIU Lu;ZHANG Yihua;ZHU Dexiang;L;L(Shenzhen Prevention and Treatment Center for Occupational Diseases,ShenZhen,Guangdong 518020, China;Hunan Prevention and Treatment Center for Occupational Diseases, Changsha , Hunan 410007, China)
出处 《职业卫生与应急救援》 2018年第2期101-104,112,共5页 Occupational Health and Emergency Rescue
基金 深圳市科技创新委员会科技项目(JCYJ20150403091305477) 深圳市重大职业病诊疗技术实验室(CXB201111250112a) 国家职业病临床重点专科建设项目(WY2011873)
关键词 尘肺病 疾病认知 量表 信度 效度 pneumoconiosis cognition of disease scale reliability validity
  • 相关文献

参考文献3

二级参考文献21

  • 1Global Initiative for Chronic Obstructive Lung Disease.Global Strategy for the Diagnosis,Management and Prevention of COPD,Updated January 2015[EB/OL].http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Feb1 8.pdf.
  • 2Global Initiative for Asthma.Global Strategy for Asthma Management and Prevention,Updated May 2014[EB/OL].http://www.ginasthma.org/local/uploads/files/GINA_Report_2014_Aug12.pdf.
  • 3Magnussen H,Disse B,Rodriguez-Roisin R,et al.Withdrawal of inhaled glucocorticoids and exacerbations of COPD[J].N Engl J Med,2014,371 (14):1285-1294.
  • 4van der Valk P,Monninkhof E,van der Palen J,et al.Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease:the COPE study[J].Am J Respir Crit Care Med,2002,166(10):1358-1363.
  • 5Zheng JP,Wen FQ,Bai CX,et al.Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON):a randomised,double-blind placebo-controlled trial[J].Lancet Respir Med,2014,2(3):187-194.
  • 6Donohue JF,Anzueto A,Brooks J,et al.A randomized,doubleblind dose-ranging study of the novel LAMA GSK573719 in patients with COPD[J].Respir Med,2012,106(7):970-979.
  • 7Celli B,Crater G,Kilbride S,et al.Once-daily umeclidinium/ vilanterol 125/25 mcg in COPD:a randomized,controlled study[J].Chest,2014,145(5):981-991.
  • 8Lehouck A,Mathieu C,Carremans C,et al.High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease[J].Ann Intern Med,2012,156(2):105-114.
  • 9Criner GJ,Connett JE,Aaron SD,et al.Simvastatin for the prevention of exacerbations in moderate-to-severe COPD[J].N Engl J Med,2014,370(23):2201-2210.
  • 10Blanco I,Santos S,Gea J,et al.Sildenafil to improve respiratory rehabilitation outcomes in COPD:a controlled trial[J].Eur Respir J,2013,42(4):982-992.

共引文献5154

同被引文献82

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部